Investors
Stock Quote
ICCC Stock Price
Data provided by Yahoo Finance. Prices may be delayed. Not financial advice.
Corporate Presentation
Press Releases
Recent News | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014
SEC Filings
SEC Filings
Annual Report and Proxy
Corporate
Governance
ICCC Code of Conduct
Charter and Powers of the Audit Committee
Nominating Committee Charter
Management & Directors
2019 Press Releases
11-11-19 ImmuCell Announces Unaudited Financial Results for Third Quarter of 2019
11-05-19 ImmuCell to Announce Unaudited Financial Results for Third Quarter of 2019
08-29-19 ImmuCell Receives FDA Response To First CMC Submission for Re-Tain™
08-12-19 ImmuCell Announces Unaudited Financial Results for Second Quarter of 2019
08-06-19 ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2019
05-13-19 ImmuCell Announces Unaudited Financial Results for First Quarter of 2019
05-07-19 ImmuCell to Announce Unaudited Financial Results for First Quarter of 2019
03-29-19 ImmuCell Corporation Announces Closing of $9 Million Public Offering of Common Stock
03-27-19 ImmuCell Corporation Announces Pricing of $9.0 Million Public Offering of Common Stock
03-26-19 ImmuCell Corporation Announces Commencement of Public Offering of Common Stock
02-13-19 ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2018
02-06-19 ImmuCell to Announce Financial Results for Fourth Quarter and Full Year 2018
Company Contact
Olivier te Boekhorst
President & CEO
investor.relations@immucell.com
Investor Contact
Lytham Partners, LLC
iccc@lythampartners.com
602.889.9700